Combined medicine for preventing and/or repairing heart injuries caused by atmospheric pollution
A drug, prevention and control technology, applied in the direction of drug combination, anhydride/acid/halide active ingredients, medical preparations containing active ingredients, etc., can solve problems such as inconspicuous pollution control
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Embodiment 1 A kind of combined medicine
[0044] The combination medicine of embodiment 1 comprises A component and B component, and the composition (by weight) of A component and B component is respectively as follows:
[0045] Component A: 4.32 parts of taurine, 0.012 part of coenzyme Q10;
[0046] B component: α-linolenic acid 0.66 part, linoleic acid 0.1728 part, eicosapentaenoic acid (EPA) 0.2196 part, docosahexaenoic acid (DHA) 0.144 part.
[0047] The weight ratio of A component and B component is about 3.62:1.
[0048] The preparation method of component A is as follows: mixing taurine and coenzyme Q10 to obtain component A.
[0049] The preparation method of component B is as follows: α-linolenic acid, linoleic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are mixed to obtain component B.
Embodiment 2
[0050] Embodiment 2 A kind of combined medicine
[0051] The combination medicine of embodiment 2 comprises A component and B component, and the composition (by weight) of A component and B component is respectively as follows:
[0052] Component A: 2.16 parts of taurine, 0.006 part of coenzyme Q10;
[0053] B component: α-linolenic acid 0.99 part, linoleic acid 0.2592 part, eicosapentaenoic acid (EPA) 0.3294 part, docosahexaenoic acid (DHA) 0.216 part.
[0054] The weight ratio of A component and B component is about 1.21:1.
[0055] The preparation method of component A is as follows: mixing taurine and coenzyme Q10 to obtain component A.
[0056] The preparation method of component B is as follows: α-linolenic acid, linoleic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are mixed to obtain component B.
Embodiment 3
[0057] Embodiment 3 A kind of combination medicine
[0058] The combination medicine of embodiment 3 comprises A component and B component, and the composition (by weight) of A component and B component is respectively as follows:
[0059] Component A: 6.48 parts of taurine, 0.018 part of coenzyme Q10;
[0060] B component: α-linolenic acid 0.33 part, linoleic acid 0.0864 part, eicosapentaenoic acid (EPA) 0.1098 part, docosahexaenoic acid (DHA) 0.072 part.
[0061] The weight ratio of A component and B component is about 10.86:1.
[0062] The preparation method of component A is as follows: mixing taurine and coenzyme Q10 to obtain component A.
[0063] The preparation method of component B is as follows: α-linolenic acid, linoleic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are mixed to obtain component B.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com